Claire Julian-Reynier

Summary

Country: France

Publications

  1. pmc Psychometric properties of a French version of a Dutch scale for assessing breast and body image (BBIS) in healthy women
    Noémie Resseguier
    INSERM, U912, SESSTIM, Marseille, France
    BMC Womens Health 13:24. 2013
  2. doi BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis
    Claire Julian-Reynier
    INSERM, U912, Marseille, France
    Genet Med 14:527-34. 2012
  3. doi [Genetic predisposition to breast and ovarian cancer: importance of test results]
    Claire Julian-Reynier
    UMR 912, INSERM, IRD, Universite d Aix Marseille, Institut Paoli Calmettes 232, boulevard Sainte Marguerite 13273 Marseille cedex 09, France
    Med Sci (Paris) 27:657-61. 2011
  4. doi Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer
    Claire Julian-Reynier
    U912, INSERM, IRD, Universite Aix Marseille, 232 Bd Sainte Marguerite, 13273 Marseille Cedex 09, France
    J Clin Oncol 27:4475-80. 2009
  5. pmc Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
    Claire Julian-Reynier
    INSERM, U912, IRD, Institut Paoli Calmettes, Marseille, France
    Eur J Hum Genet 19:500-6. 2011
  6. ncbi Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients
    Julien Mancini
    INSERM UMR379, Epidemiology and Social Sciences Unit, Institut Paoli Calmettes, 232 Bd Ste Marguerite, B P 156, F 13273, Marseille Cedex 09, France
    Qual Life Res 15:1063-8. 2006
  7. doi Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics
    Claire Julian-Reynier
    INSERM, UMR912, Institut Paoli Calmettes, Marseille, France
    Genet Med 12:801-7. 2010
  8. doi Genetics in clinical practice: general practitioners' educational priorities in European countries
    Claire Julian-Reynier
    INSERM, UMR912, Marseilles, France
    Genet Med 10:107-13. 2008
  9. ncbi Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing
    Julien Mancini
    INSERM, UMR379, Institut Paoli Calmettes, Epidemiology and Social Sciences Unit, 232 Bd Ste Marguerite, Marseille F 13000, France
    Eur J Cancer 42:871-81. 2006
  10. doi [Perception by cancer patients of biomedical research in the era of large-scale biobanking]
    Julien Mancini
    Aix Marseille Univ, UMR 912, 13009, Marseille, France
    Med Sci (Paris) 28:28-32. 2012

Detail Information

Publications24

  1. pmc Psychometric properties of a French version of a Dutch scale for assessing breast and body image (BBIS) in healthy women
    Noémie Resseguier
    INSERM, U912, SESSTIM, Marseille, France
    BMC Womens Health 13:24. 2013
    ..The aim of this study was to examine the psychometric properties of a generic scale assessing breast and body image (BBIS) in healthy women tested for BRCA1/2 mutations...
  2. doi BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis
    Claire Julian-Reynier
    INSERM, U912, Marseille, France
    Genet Med 14:527-34. 2012
    ..To assess the impact of BRCA1/2 test results on carriers' reproductive decision-making and the factors determining their theoretical intentions about preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND)...
  3. doi [Genetic predisposition to breast and ovarian cancer: importance of test results]
    Claire Julian-Reynier
    UMR 912, INSERM, IRD, Universite d Aix Marseille, Institut Paoli Calmettes 232, boulevard Sainte Marguerite 13273 Marseille cedex 09, France
    Med Sci (Paris) 27:657-61. 2011
    ....
  4. doi Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer
    Claire Julian-Reynier
    U912, INSERM, IRD, Universite Aix Marseille, 232 Bd Sainte Marguerite, 13273 Marseille Cedex 09, France
    J Clin Oncol 27:4475-80. 2009
    ..The aim of this study was to determine French professionals' attitudes about the acceptability of PGD and PND for inherited predisposition to cancer...
  5. pmc Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
    Claire Julian-Reynier
    INSERM, U912, IRD, Institut Paoli Calmettes, Marseille, France
    Eur J Hum Genet 19:500-6. 2011
    ..Informed decision-making involves letting women know whether opting for RRSO and breast MRI surveillance is as effective in terms of survival as RRM and RRSO...
  6. ncbi Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients
    Julien Mancini
    INSERM UMR379, Epidemiology and Social Sciences Unit, Institut Paoli Calmettes, 232 Bd Ste Marguerite, B P 156, F 13273, Marseille Cedex 09, France
    Qual Life Res 15:1063-8. 2006
    ..The Decisional Conflict Scale (DCS, 16 items, 5 dimensions) designed to measure the level of decisional conflict experienced by patients making health care decisions has not yet been validated in French...
  7. doi Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics
    Claire Julian-Reynier
    INSERM, UMR912, Institut Paoli Calmettes, Marseille, France
    Genet Med 12:801-7. 2010
    ..To investigate the medical and psychosocial factors determining the time to prophylactic surgery of unaffected women carriers of a deleterious BRCA1/2 mutation...
  8. doi Genetics in clinical practice: general practitioners' educational priorities in European countries
    Claire Julian-Reynier
    INSERM, UMR912, Marseilles, France
    Genet Med 10:107-13. 2008
    ..To assess how general practitioners (GPs) from European countries prioritized their genetic educational needs according to their geographic, sociodemographic, and educational characteristics...
  9. ncbi Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing
    Julien Mancini
    INSERM, UMR379, Institut Paoli Calmettes, Epidemiology and Social Sciences Unit, 232 Bd Ste Marguerite, Marseille F 13000, France
    Eur J Cancer 42:871-81. 2006
    ..95%; P = 0.009). In addition to a consultation providing more tailored information, a standardized written document improved the decision-making process involved in giving informed consent to genetic testing...
  10. doi [Perception by cancer patients of biomedical research in the era of large-scale biobanking]
    Julien Mancini
    Aix Marseille Univ, UMR 912, 13009, Marseille, France
    Med Sci (Paris) 28:28-32. 2012
    ..Patients are globally expressing a wish for more proposals to participate in research in collaboration with scientific teams...
  11. pmc Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study
    Francois Eisinger
    Institut Paoli Calmettes, Marseille, France
    Eur J Hum Genet 20:981-3. 2012
    ....
  12. ncbi Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services
    Claire Julian-Reynier
    1INSERM U379, Epidemiology and Social Sciences Applied to Medical Innovation, Institut Paoli Calmettes, Marseille, France
    Eur J Hum Genet 11:725-36. 2003
    ..In conclusion, this paper adds clinical relevance to the research evidence. We propose specific steps that could be integrated in standard clinical practice based on current evidence for their usefulness/effectiveness...
  13. doi Patients' regrets after participating in a randomized controlled trials depended on their involvement in the decision making
    Julien Mancini
    Aix Marseille University, School of Medicine, Marseille F 13385, France
    J Clin Epidemiol 65:635-42. 2012
    ..To identify the factors associated with long-term regrets expressed a posteriori by randomized controlled trial (RCT) participants questioned about their decision to participate in an RCT...
  14. doi Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view
    Isabelle Pellegrini
    INSERM, U912 SE4S, Marseille, France
    Psychooncology 19:472-9. 2010
    ..The aim of this study on primary breast cancer patients undergoing adjuvant tamoxifen treatment was to determine how their perceptions of the treatment and their experience of side-effects contributed to their adherence to the treatment...
  15. doi Development of a scale for assessing respondents' perceptions of health research questionnaires (the REP-HQ Scale)
    Anne Deborah Bouhnik
    Institut National de la Sante et de la Recherche Medicale, UMR912 Health Economy, Social Sciences and Medical Information Processing SESSTIM, 232, boulevard de Sainte Marguerite, 13009 Marseille, France
    J Clin Epidemiol 65:1098-106. 2012
    ..To develop a scale for assessing Respondents' Perceptions of Health Research Questionnaires (the REP-HQ Scale) and test this scale psychometrically...
  16. ncbi Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultation
    Laetitia Huiart
    Epidemiology and Social Sciences Unit INSERM U379, Institut Paoli Calmettes, 232 Bd Ste Marguerite, 13273 Marseille Cedex 09, France
    J Clin Epidemiol 55:665-75. 2002
    ..The question arises as to whether a more comprehensive approach should be implemented and how to go about providing efficient cancer risk information in the context of health care systems...
  17. ncbi Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer
    Claire Julian-Reynier
    Institut National de la Sante et de la Recherche Medicale, U379, Epidemiology and Social Sciences Unit, Marseille, France
    J Clin Oncol 25:3038-44. 2007
    ..Cancer patients participating in randomized controlled trials (RCTs) have not been found to have better clinical outcomes than other patients. Our objective was to assess the impact of RCTs on patients' satisfaction with care...
  18. doi Cancer survivors: familial risk perception and management advice given to their relatives
    Francois Eisinger
    UMR912, Institut Paoli Calmettes, Marseille, France
    Fam Cancer 10:147-55. 2011
    ..If survivors were better informed, they could play a critical role by conveying relevant and sound risk reduction messages to their relatives...
  19. ncbi Behavioral and economic impact of a familial history of cancers
    Francois Eisinger
    Institute Paoli Calmettes INSERM UMR, Marseille, France
    Fam Cancer 4:307-11. 2005
    ....
  20. doi [Targeted chemotherapy for breast cancer: patients perception of the use of tumor gene profiling approaches to better adapt treatments]
    Isabelle Pellegrini
    Inserm UMR912, IRD, Marseille, France
    Med Sci (Paris) 28:24-7. 2012
    ..This will ensure that those who agree to their tumor gene analysis have realistic expectations and sound deductions of the final result disclosure process...
  21. doi Consent for biobanking: assessing the understanding and views of cancer patients
    Julien Mancini
    Universite d Aix Marseille, Marseille, France
    J Natl Cancer Inst 103:154-7. 2011
    ..We conclude that the opt-in consent procedure is positively perceived by most patients but should be improved for a better understanding and possibly an even better adherence to the consent process...
  22. ncbi France: genetics education for non-genetics health care providers
    Claire Julian-Reynier
    INSERM, UMR379, Epidemiology and Social Sciences Unit, Institut Paoli Calmettes, Marseille, France
    Community Genet 9:227-34. 2006
    ..This paper explores the treatment of medical genetics in undergraduate medical education, specialists' training and continuing medical education (CME) for general practitioners, specialists, nurses and midwives...
  23. ncbi Decision-making and breast cancer clinical trials: how experience challenges attitudes
    Julien Mancini
    INSERM, UMR379, Epidemiology and Social Sciences Unit, Paoli Calmettes Institute, Marseille, F 13273, France
    Contemp Clin Trials 28:684-94. 2007
    ..The aim of this study was to measure women's preferences about decision-making and their impact to participate or not to a hypothetical randomised controlled trial (RCT)...
  24. doi Assessing educational priorities in genetics for general practitioners and specialists in five countries: factor structure of the Genetic-Educational Priorities (Gen-EP) scale
    Jean Marc Calefato
    INSERM, UMR912, Aix Marseille Universite, Marseille, France
    Genet Med 10:99-106. 2008
    ..The objective of this study was to determine its factor structure, to test scaling assumptions and to determine internal consistency...